JO
HCAT icon

John Overdeck’s Health Catalyst HCAT Stock Holding History

John Overdeck’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3K Buy
+13,713
New +$19.8K ﹤0.01% 4973
2026
Q1 		– Sell
-100,097
Closed -$239K – 4722
2025
Q4 		$239K Sell
100,097
-76,994
-43% -$211K ﹤0.01% 3691
2025
Q3 		$505K Buy
177,091
+134,665
+317% +$461K ﹤0.01% 2976
2025
Q2 		$160K Buy
+42,426
New +$167K ﹤0.01% 2950
2025
Q1 		– Sell
-70,208
Closed -$496K – 3312
2024
Q4 		$496K Buy
+70,208
New +$559K ﹤0.01% 2544
2024
Q2 		– Sell
-62,463
Closed -$470K – 3150
2024
Q1 		$470K Sell
62,463
-145,376
-70% -$1.33M ﹤0.01% 2364
2023
Q4 		$1.92M Buy
207,839
+92,419
+80% +$755K ﹤0.01% 1595
2023
Q3 		$1.17M Sell
115,420
-148,963
-56% -$1.78M ﹤0.01% 1843
2023
Q2 		$3.3M Sell
264,383
-156,096
-37% -$1.86M 0.01% 1135
2023
Q1 		$4.91M Buy
420,479
+60,578
+17% +$772K 0.01% 919
2022
Q4 		$3.83M Buy
359,901
+49,103
+16% +$474K 0.01% 982
2022
Q3 		$3.02M Sell
310,798
-115,818
-27% -$1.53M 0.01% 970
2022
Q2 		$6.18M Buy
426,616
+290,503
+213% +$4.95M 0.02% 679
2022
Q1 		$3.56M Buy
+136,113
New +$3.86M 0.01% 1089
2021
Q2 		– Sell
-186,261
Closed -$8.71M – 4262
2021
Q1 		$8.71M Buy
186,261
+117,607
+171% +$5.7M 0.02% 762
2020
Q4 		$2.99M Buy
68,654
+44,978
+190% +$1.66M 0.01% 1238
2020
Q3 		$867K Buy
+23,676
New +$804K ﹤0.01% 1856
2020
Q2 		– Sell
-9,441
Closed -$247K – 3176
2020
Q1 		$247K Buy
+9,441
New +$288K ﹤0.01% 2482

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

John Overdeck's HCAT Position: Q2 2026 in Review

John Overdeck opened a new position in Health Catalyst (HCAT) in Q2 2026: 13,713 shares worth $27.3K. The stake represents ﹤0.01% of the portfolio and ranks #4973 among its holdings. This is a return to the name: John Overdeck previously reported a position in HCAT as recently as Q4 2025.

John Overdeck first reported a position in HCAT in Q1 2020 and has held it in 18 quarters since. The position peaked at $8.71M in Q1 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • John Overdeck held 13,713 shares of Health Catalyst worth $27.3K as of Q2 2026.
  • Health Catalyst was a new John Overdeck position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4973 holding.
  • John Overdeck first reported a position in Health Catalyst in Q1 2020 and has held it in 18 quarters since.
  • John Overdeck's Health Catalyst position peaked at $8.71M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.